| Why We Should Reexamine the “Golden Age” of Antibiotics in Social Context KM Meagher AMA journal of ethics 26 (5), 418-428, 2024 | | 2024 |
| Can One Health Policy Help Us Expand an Ethics of Interconnection and Interdependence? KM Meagher AMA journal of ethics 26 (2), 162-170, 2024 | | 2024 |
| AMA Journal of Ethics® KM Meagher MEDICINE AND SOCIETY 26 (2), 162, 2024 | | 2024 |
| Data Science for Global Health K Meagher, D Falzon, Z Temesgen Global Health Essentials, 389-393, 2023 | | 2023 |
| Translational justice in human gene editing: bringing end user engagement and policy together MA Allyse, KM Meagher, M Michie, R Isasi, KE Ormond, N Bonhomme, ... The American Journal of Bioethics 23 (7), 55-58, 2023 | 1 | 2023 |
| A public health ethics framework for populations with limited English proficiency SA Chipman, K Meagher, AK Barwise The American Journal of Bioethics, 1-16, 2023 | 2 | 2023 |
| The Slippery Slope of Prenatal Testing for Social Traits C Canter, K Foley, SL Callier, KM Meagher, M Waltz, A Washington, ... The American Journal of Bioethics 23 (3), 36-38, 2023 | | 2023 |
| The new precision stewards? KM Meagher, S Watson, GA Suh, A Virk Journal of Personalized Medicine 12 (8), 1308, 2022 | 4 | 2022 |
| Excellent Traits in Public Health: Virtuous Structures and the Structure of Virtue KM Meagher Public Health Ethics 15 (1), 16-22, 2022 | | 2022 |
| Lay understandings of drug‐gene interactions: The right medication, the right dose, at the right time, but what are the right words? KM Meagher, K Stuttgen Finn, SH Curtis, J Borucki, AT Beck, AW Cheema, ... Clinical and translational science 15 (3), 721-731, 2022 | 4 | 2022 |
| Asking and Answering Ethical Questions with the Youngest Learners KM Meagher, LM Lee YC Young Children 76 (4), 78-83, 2021 | | 2021 |
| Bioethics theory-building for public health KM Meagher The American Journal of Bioethics 21 (9), 53-56, 2021 | 1 | 2021 |
| Bioethics advocacy in ethos, practice and metrics AK Barwise, B Thorsteinsdottir, MA Allyse, MJ Clarke, KM Meagher The American Journal of Bioethics 21 (2), 69-72, 2021 | 3 | 2021 |
| Communicating unexpected pharmacogenomic results to biobank contributors: a focus group study KM Meagher, SH Curtis, S Borucki, A Beck, T Srinivasan, A Cheema, ... Patient Education and Counseling 104 (2), 242-249, 2021 | 11 | 2021 |
| Ethical challenges in COVID-19 Biospecimen research: perspectives from institutional review board members and Bioethicists MI Lapid, KM Meagher, HC Giunta, BL Clarke, Y Ouellette, TL Armbrust, ... Mayo Clinic Proceedings 96 (1), 165-173, 2021 | 14 | 2021 |
| A new governance approach to regulating human genome editing JM Conley, AM Davis, GE Henderson, ET Juengst, KM Meagher, ... North Carolina journal of law & technology 22 (2), 107, 2020 | 6 | 2020 |
| Parallel but connected: Nuances of conducting behavioral and social science research alongside ethically challenging HIV remission trials GE Henderson, S Rennie, A Corneli, K Meagher, RJ Cadigan, E Kroon, ... Contemporary Clinical Trials Communications 19, 100594, 2020 | 3 | 2020 |
| COVID-19 ethics and research KM Meagher, NW Cummins, AE Bharucha, AD Badley, LL Chlan, ... Mayo Clinic Proceedings 95 (6), 1119-1123, 2020 | 77 | 2020 |
| At a moment’s notice: community advisory board perspectives on biobank communication to supplement broad consent KM Meagher, SH Curtis, KO Gamm, EJ Sutton, JB McCormick, RR Sharp Public health genomics 23 (3-4), 77-89, 2020 | 5 | 2020 |
| Assessing the implications of positive genomic screening results M Waltz, KM Meagher, GE Henderson, KAB Goddard, K Muessig, JS Berg, ... Personalized medicine 17 (2), 101-109, 2020 | 9 | 2020 |
